SNB-19 In Vitro Resazurin Assay (Cell Viability)

CAT#: ITS-1022-YF4626
Target Cell Organism: Human
Target Cell Name: SNB-19
Assay Type: Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Overview
This assay is to provide SNB-19-based In Vitro Resazurin Assay (Cell Viability) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
SNB-19
Target Cell Organism
Human
Target Cell Background
SNB-19 is a human glioblastoma cell line that was isolated from a left parieto-occipital glioblastoma of a 47-year-old male patient in 1980. In a 1988 study, published in Cancer Research Journal, the SNB-19 cell line was the most clonogenic in soft agar and showed the most tumorigenicity in nude mice.
Related Diseases
Glioblastoma
Research Area
Oncology
Assay Name
In Vitro Resazurin Assay (Cell Viability)
Short Description
SNB-19-cell based In Vitro Resazurin Assay (Cell Viability)
Assay Description
Resazurin is a non-fluorescent (blue in color) component of alamar Blue reagents, which can enter viable cells. After entering in to viable cells, resazurin is converted to resorufin by NADH, NAD (P) H or FADH2-dependent cellular oxidoreductase.
Assay Type
Cell Viability/Cytotoxicity and Antiproliferative Assays
Assay Type Details
Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.
Assay Subtype
Cell Viability Assay
Assay MOA
Cell-based Viability Assays Based on Cellular Enzymes and Proteins
For Research Use Only | Not For Clinical Use
Online Inquiry